Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury

Clinical trial NCT04528550 · UNKNOWN

Trial details

NCT number: NCT04528550
Sponsor: Shanghai Changzheng Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Spinal Cord Injury

Start date: 2020-10-01
Primary completion: 2023-10-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.